NCT03855956

Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis

A Randomized, Double-blind, Controlled, Clinical Food Study to Evaluate the Effect of KB174 Compared to an Easily Digestible Polysaccharide on Function and Structure of the Gut Microbiome in Subjects With Well-compensated Cirrhosis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Kaleido Biosciences · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This randomized, double-blind, controlled, clinical food study aims to explore KB174, a novel mixture of oligosaccharides, and maltodextrin, an easily digestible polysaccharide, on gut microbiome structure and function in subjects with well-compensated cirrhosis.

Conditions

• Early Cirrhosis

Interventions

Type	Name	Description
OTHER	KB174	KB174 is a novel mixture of oligosaccharides.
OTHER	Maltodextrin	Maltodextrin is a commercially available easily digestible polysaccharide.

Timeline

• Start date: 2019-02-27
• Primary completion: 2019-10-01
• Completion: 2019-10-01
• First posted: 2019-02-27
• Last updated: 2020-05-14

Locations

4 sites across 1 country: United States